ALS Clinical Trials in Houston

Showing 41-60 of 61 trials

ACT for CP Individual Patient Expanded Access IND Protocol

NCT03203941

Individual patient expanded access protocol for a child with cerebral palsy (CP) who has autologous umbilical cord blood available and who is ineligible to participate in other stem cell studies for children with CP.

Cerebral Palsy

Charles Cox

Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

NCT01603641

This study will evaluate the long-term safety of BOTOX® (botulinum toxin Type A) for the treatment of pediatric lower limb spasticity.

PediatricsMuscle SpasticityCerebral Palsy

Allergan370 participantsStarted Nov 2012

Pasadena, California, United States • Pomona, California, United States • San Diego, California, United States +53 more locations

PreviousPage 3 of 4Next

ACT for CP Individual Patient Expanded Access IND Protocol

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

ALS Trials in Other Cities

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

T-Regulatory Cells in Amyotrophic Lateral Sclerosis

SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)

Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Minocycline to Treat Amyotrophic Lateral Sclerosis

Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

Study of Electrical Impedance Myography (EIM) in ALS

Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis

Other Conditions in Houston